Go to home page - PHARMAC - Pharmaceutical Management Agency
Leading Edge Medicines Management home
Patients & Consumers Health Professionals District Health Boards Pharmaceutical Suppliers

Wed Nov 25 2009 NZST

Search archive

2009 / 07

Your search is limited to one month, search the whole site for archive.

Prev, Next – Page 1 of 2 (18 documents)

icon

Proposals regarding diabetes management products. Closed (4 pages, 146 KB)
2009/07/31
archive, consultation

31 July 2009 Proposals regarding diabetes management products Further to our notification letter dated 8 June 2009 regarding new and amended listings for diabetes management products, PHARMAC is seeking feedback on the following additional proposals: • The listing of the…

text


icon

Proposal to list a new brand of amoxycillin 125 mg per 5 ml suspension. Closed (2 pages, 148 KB)
2009/07/31
WhatsNew, archive, consultation

31 July 2009 Proposal to list a new brand of amoxycillin 125 mg per 5 ml suspension PHARMAC is seeking feedback on a proposal to fund Sandoz Pty Limited’s brand of amoxycillin granules for oral liquid 125 mg per 5…

text


icon

Tender Results (5 pages, 124 KB)
2009/07/31
archive, notification

31 July 2009 TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products listed in the Invitation to Tender dated 23…

text


icon

Proposal relating to alendronate, aprepitant, raltegravir, levodopa with carbidopa, timolol and dorzolamide with timolol. Closed (5 pages, 104 KB)
2009/07/30
archive, consultation

30 July 2009 Proposal relating to alendronate, aprepitant, raltegravir, levodopa with carbidopa, timolol and dorzolamide with timolol Proposal summary PHARMAC is seeking feedback on a proposal to fund the antinausea treatment aprepitant (Emend), the antiretroviral agent raltegravir (Isentress) and a…

text


icon

Proposal to widen access to gemcitabine hydrochloride. Closed (3 pages, 59 KB)
2009/07/29
archive, consultation

29 July 2009 Proposal to widen access to gemcitabine hydrochloride PHARMAC is seeking feedback on a proposal to widen funded access to gemcitabine hydrochloride. In summary, the proposal involves: § Widening access to subsidised gemcitabine to include funding for adjuvant…

text


icon

Listing of Low Molecular Weight Heparin in the Pharmaceutical Schedule approved (7 pages, 48 KB)
2009/07/28
archive, notification

28 July 2009 Listing of Low Molecular Weight Heparin in the Pharmaceutical Schedule PHARMAC is pleased to announce the listing of the Clexane brand of low molecular weight heparin on the Pharmaceutical Schedule from 1 August 2009. In summary, the…

text


icon

Proposal to amend the listings for metoprolol succinate (Betaloc CR & AFT-Metoprolol CR) and goserelin acetate (Zoladex). Closed (3 pages, 59 KB)
2009/07/24
archive, consultation

24 July 2009 Proposal to amend the listings for metoprolol succinate (Betaloc CR & AFT-Metoprolol CR) and goserelin acetate (Zoladex) PHARMAC is seeking feedback on a proposal to fully subsidise Betaloc CR (the current endorsement would also be removed) and…

text


icon

Notification of proposal relating to cyclosporin A and clozapine approved (2 pages, 114 KB)
2009/07/15
archive, notification

15 July 2009 Proposal relating to cyclosporin A and clozapine approved PHARMAC is pleased to announce the approval of the proposal relating to the supply of Neoral (cyclosporin A 25 mg, 50 mg and 100 mg capsules and 100 mg…

text


icon

Notification of healthE Fatty Cream (oil in water emulsion) funding approval (1 page, 136 KB)
2009/07/14
archive, notification

14 July 2009 healthE Fatty Cream (oil in water emulsion) funding approved PHARMAC is pleased to announce the approval of a supply agreement with Jaychem Industries Ltd for oil in water emulsion cream (healthE Fatty Cream). The supplier of Lemnis…

text


icon

Notification of removal of the dipyridamole Special Authority (1 page, 25 KB)
2009/07/14
archive, notification

14 July 2009 Removal of the Dipyridamole Special Authority PHARMAC is pleased to announce that the Special Authority that applies to dipyridamole was removed from 1 July 2009. Dipyridamole is now fully funded without restriction. Background Following a recommendation from…

text


Prev, Next – Page 1 of 2 (18 documents)

Search tips

Search or Browse

To search for a document enter a search term into the search form and activate the Search button.

Documents may be browsed by date, eg; Today, November, 2009.

Past years can be browsed too...
2008, 2007, 2006, 2005, 2004, 2003, 2002, 2001, 2000, 1999, 1998.

Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg;
Media releases from 2009

Search terms

Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.

Document tags (shown in bolded red below document date) have highest priority when search results are ranked, followed by title, abstract and full text of document (if available). Tags in use include...
AnnualReport, AnnualReview, archive, BIM, BoardPaper, BusinessPlan, CAC, CACminutes, consultation, delete, EC, ECForm, EOI, etender, herceptin, inpharmation, leaflet, media, notification, OIA, opinion, PatientGuide, policy, poster, PTAC, PTACminutes, PTACSCMinutes, Q&A, release, resource, RFI, RFP, SAForm, SAForms, schedule, SchedulePublications, SectionH, SOI, TAR, tender, update, vacancy, WhatsNew.

Documents with related dates can be browsed through the date component links below the document title.

Remember to group or statements with parentheses if they are beside and statements.

Search examples

consultation
Search for consultations
media and not antibiotics
Search for media related documents that don't mention antibiotics.
(media or consultation) and vaccines
Search for media releases and consultation documents mentioning vaccinations.